Welcome to the second installment of the Guidelines International Series, where we will be delving into the European Respiratory Society (ERS). ERS stands as the largest respiratory medicine organization in Europe, with members hailing from 160 countries. As the premier membership organization for respiratory professionals, ERS is committed to advancing excellence in the study, research, and practice of respiratory medicine for the betterment of professionals and the wider public.

ERS consistently produces a variety of guidelines each year, with three guidelines already released in 2024 alone. Below, you will find the guidelines from this year and last year, along with their respective objectives.

2024 ERS Guidelines

Joint ERS/EACTS/ESTS clinical practice guidelines on adults with spontaneous pneumothorax

  • Published: May 28, 2024.
  • Objective: The management of spontaneous pneumothorax (SP) continues to be a topic of debate, with multiple proposed strategies. This collaborative clinical practice guideline from the ERS, EACTS, and ESTS societies offers evidence-based recommendations for the optimal management of SP.

European Respiratory Society Clinical Practice Guideline on symptom management for adults with serious respiratory illness

  • Published: May 8, 2024
  • Objective: Respiratory symptoms are common and can significantly impact the quality of life for individuals with respiratory diseases. The European Respiratory Society (ERS) task force set out to offer recommendations for managing symptoms in individuals with severe respiratory conditions.

ERS/EBMT clinical practice guideline on treatment of pulmonary chronic graft-versus-host disease in adults

  • Published: March 14, 2024
  • Objective: The aim of the collaborative effort between the European Respiratory Society and the European Society for Blood and Marrow Transplantation Task Force was to establish evidence-based recommendations for the treatment of bronchiolitis obliterans syndrome, a pulmonary complication of chronic graft-versus-host disease, in adult patients.

2023 ERS Guidelines

European Respiratory Society short guidelines for the use of as-needed ICS/formoterol in mild asthma

  • Published: October 12, 2023
  • Objective: Recent clinical trials on the as-needed fixed-dose combination of inhaled corticosteroid (ICS)/formoterol have yielded compelling new evidence that may prompt a reevaluation of current medical practices. In response to these findings, the European Respiratory Society established a Task Force to develop evidence-based recommendations regarding the use of as-needed ICS/formoterol as a treatment for mild asthma.

European Respiratory Society clinical practice guideline: palliative care for people with COPD or interstitial lung disease

  • Published: August 17, 2023.
  • Objective: There is a growing recognition of the palliative care needs of individuals with COPD or interstitial lung disease (ILD). The European Respiratory Society (ERS) task force set out to offer recommendations for the implementation and incorporation of palliative care into the respiratory care of adult patients with COPD or ILD.

ERS/ESICM/ESCMID/ALAT guidelines for the management of severe community-acquired pneumonia

  • Published: April 3, 2023.
  • Objective: Severe community-acquired pneumonia (sCAP) is linked to significant morbidity and mortality rates. Despite the presence of European and non-European guidelines for community-acquired pneumonia, there is a notable absence of specific guidelines tailored to sCAP.

We trust that you found these guidelines as intriguing as we did. Examining international society guidelines can broaden our understanding of recommendations beyond our own, thereby enriching our knowledge base. Please let us know if there are any international societies you would like us to look into and don’t forget to sign up for alerts and stay informed on the latest published guidelines and articles.

Copyright © 2024 Guideline Central, All rights reserved.